Northwest & Ethical Investments L.P. Myriad Genetics Inc Transaction History

Northwest & Ethical Investments L.P.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2013 Jul 08, 2025	SELL	N/A	-116,720 Closed	0 $0
Q2 2013 Jul 08, 2025	BUY	N/A	22,930 Added 24.45%	116,720 $3.14 Billion
Q1 2013 Jul 08, 2025	BUY	N/A	93,790 New	93,790 $2.38 Billion
Q4 2012 Jul 07, 2025	BUY	N/A	1,020 Added 1.16%	89,220 $2.43 Billion
Q3 2012 Jul 07, 2025	BUY	N/A	4,270 Added 5.09%	88,200 $2.38 Billion

Q2 2012 Jul 07, 2025	BUY	N/A	83,930	83,930 $2 Billion

242

92.7M

86.1K

18.9K

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $541M
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

Get notified when there are updates to the investment portfolio of Northwest & Ethical Investments L.P., based on Form 13F filings with the SEC.

Stay updated on Northwest & Ethical Investments L.P. with notifications on news.